Yusimry Interactions
There are 552 drugs known to interact with Yusimry (adalimumab), along with 8 disease interactions. Of the total drug interactions, 300 are major, 243 are moderate, and 9 are minor.
- View all 552 medications that may interact with Yusimry
- View Yusimry disease interactions (8)
Most frequently checked interactions
View interaction reports for Yusimry (adalimumab) and the medicines listed below.
- acetaminophen
- amitriptyline
- aspirin
- atenolol
- Ativan (lorazepam)
- Augmentin (amoxicillin / clavulanate)
- baclofen
- Benadryl (diphenhydramine)
- budesonide
- bupropion
- calcium citrate
- Celebrex (celecoxib)
- Cimzia (certolizumab)
- Claritin (loratadine)
- colesevelam
- colestipol
- Cymbalta (duloxetine)
- Daily Multiple Vitamins (multivitamin)
- dicyclomine
- estradiol
- Estroven (multivitamin with minerals)
- Fish Oil Mini (omega-3 polyunsaturated fatty acids)
- Flagyl (metronidazole)
- Flexeril (cyclobenzaprine)
- folic acid
- furosemide
- gabapentin
- metformin
- methotrexate
- pantoprazole
Yusimry disease interactions
There are 8 disease interactions with Yusimry (adalimumab) which include:
- infections
- malignancies
- neurologic reactions
- tuberculosis
- CHF
- COPD
- hematologic abnormalities
- hepatitis B
More about Yusimry (adalimumab)
- Yusimry consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.